Clinico-Radio-Histo-Molecular and Neurocognitive Characteristics of Diffuse Gliomas in Adolescent and Young Adults: A Comprehensive Review

Abstract

Background Diffuse gliomas are the most frequent neoplasms in adolescent and young adults (AYAs), especially high-grade gliomas, which have the highest mortality rate. Recent histo-molecular advances are in favour of specialized therapeutic management of AYA patients, which we have analysed in this comprehensive review of the literature. Summary A literature search was conducted to identify all studies concerning diffuse gliomas and AYAs (15-39 years). We assessed epidemiology, clinical and imaging findings, histo-molecular characteristics, neurosurgical and neuro-oncological management, prognosis, and health-related quality of life. Key messages Diffuse gliomas remain the most frequent brain tumours in the AYA population. Symptoms mainly depend on the tumour location, which varies due to histo-molecular profiles. Specific imaging patterns of histo-molecular subtypes of diffuse gliomas are identified, however no specific pattern related to the age group has been identified. The literature review favours optimizing the extent of surgical resection for diffuse gliomas, whichever the grade, and suggests a dedicated management for these patients. It seems more relevant to consider the treatment according to the histo-molecular profile of the diffuse glioma rather than the age group. Clinical trials will allow AYA patients to benefit from innovative therapies that could improve their outcome. This literature review suggests the need for a close and long-term psychological follow-up for AYA patients with brain tumour during the transitional care, during adulthood, as well as for their family members. Collaborative efforts are needed between paediatric and adult neurosurgical and neuro-oncological teams, to move forward in the therapeutic management of AYA patients harbouring diffuse gliomas.

Deciphering Glioblastoma: Fundamental and Novel Insights into the Biology and Therapeutic Strategies of Gliomas

“…Currently, the marginally effective approach to extending life expectancy in glioma patients involves surgical resection, complemented by radiation and chemotherapy using temozolomide. Despite these interventions, tumor recurrence is common, typically within 6.9 months, leading to a median survival time of only 12 to 15 months post-diagnosis [ 315 ]. Moreover, associating temozolomide with alfa interferon increases the overall survival in patients [ 316 ].…”

SCHOOL DIFFICULTIES in Children Cancer Survivors: A Narrative Review and a Teacher Point-of-View

“…Children with CNS tumors represent the population most at risk of school difficulties with significantly lower levels of QOL [8,10,29,30]. Even before diagnosis, the symptoms caused by a CNS tumor can be severe, and potential neurological dysfunctions can affect the continuation of schooling.…”

Response to – Clinico-Radio-Histo-Molecular and Neurocognitive Characteristics of Diffuse Gliomas in Adolescent and Young Adults: A Comprehensive Review

“…Dear Editor, We have read with interest the paper "Clinico-radiohisto-molecular and neurocognitive characteristics of diffuse gliomas in adolescent and young adults: a comprehensive review" by Roux et al [1], recently accepted for publication in your journal. We believe this is a muchneeded, extensive, and detailed review on the features of diffuse gliomas in the specific population of adolescents and young adults (AYA).…”